Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS

被引:221
作者
Wu, AW
Hays, RD
Kelly, S
Malitz, F
Bozzette, SA
机构
[1] JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT HLTH POLICY & MANAGEMENT, BALTIMORE, MD 21218 USA
[2] JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA
[3] RAND CORP, SANTA MONICA, CA USA
[4] UNIV CALIF LOS ANGELES, DEPT MED, LOS ANGELES, CA 90024 USA
[5] SOCIAL & SCI SYST INC, ROCKVILLE, MD USA
[6] UNIV CALIF SAN DIEGO, LA JOLLA, CA 92093 USA
关键词
HRQoL; HIV; AIDS; MOS;
D O I
10.1023/A:1018460132567
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The leading health status instruments in human immunodeficiency virus (HIV) research are based on the pool of items developed as part of the Medical Outcomes Study (MOS). The measures include the SF-20, MOS-HIV, SF-36, SF-12, SF-56, SF-38 (Patient Reported Status and Experience Survey (PARSE)), SF-21 and HIV Cost and Service Utilization Study (HCSUS) questionnaires. The instrument length ranges from 12 to 56 items, covering two to 11 dimensions. Completion requires from 2 to 14 minutes. Subscales are scored on a 0-100 scale (a higher score indicates better health); physical and mental health or overall summary scores are available for most of the measures. Three of the instruments are available in multiple languages. The instruments have been administered to over 20,000 persons with HIV in descriptive studies and clinical trials and there is substantial evidence for their reliability, construct and predictive validity and responsiveness. In several studies the measures have shown important differences between treatments. Although existing measures do not assess all domains relevant to HIV disease, additional subscales are available from the MOS pool. Some of the subscales may be prone to floor and ceiling effects. However, summary scales that encompass all of the subscales reduce this issue. Selection among MOS measures should be dictated by specific questions, the balance of available time and resources, and practical concerns.
引用
收藏
页码:531 / 554
页数:24
相关论文
共 92 条
[1]  
ARPINELLI F, 1997, DIA QUAL LIF S CHARL
[2]  
BERRY SH, 1991, MEASURING PATIENT RE
[3]  
BERTRAM S, 1993, 9 INT C AIDS BERL JU
[4]   MEASURING HEALTH CHANGES AMONG SEVERELY ILL PATIENTS - THE FLOOR PHENOMENON [J].
BINDMAN, AB ;
KEANE, D ;
LURIE, N .
MEDICAL CARE, 1990, 28 (12) :1142-1152
[5]  
Bozzette S A, 1996, Antivir Ther, V1, P21
[6]   A PERCEIVED HEALTH INDEX FOR USE IN PERSONS WITH ADVANCED HIV DISEASE - DERIVATION, RELIABILITY, AND VALIDITY [J].
BOZZETTE, SA ;
HAYS, RD ;
BERRY, SH ;
KANOUSE, DE .
MEDICAL CARE, 1994, 32 (07) :716-731
[7]   DERIVATION AND PROPERTIES OF A BRIEF HEALTH-STATUS ASSESSMENT INSTRUMENT FOR USE IN HIV DISEASE [J].
BOZZETTE, SA ;
HAYS, RD ;
BERRY, SH ;
KANOUSE, DE ;
WU, AW .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 8 (03) :253-265
[8]  
BOZZETTE SA, 1995, JAMA-J AM MED ASSOC, V273, P295, DOI 10.1001/jama.273.4.295
[9]   A RANDOMIZED TRIAL OF 3 ANTIPNEUMOCYSTIS AGENTS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BOZZETTE, SA ;
FINKELSTEIN, DM ;
SPECTOR, SA ;
FRAME, P ;
POWDERLY, WG ;
HE, WL ;
PHILLIPS, L ;
CRAVEN, D ;
VANDERHORST, C ;
FEINBERG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (11) :693-699
[10]  
BOZZETTE SA, 1996, MEASURING PATIENT CT